Masanao Nakashima
Yurigaoka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Successful Resection of Small Intestinal Stenosis After Treatment With an Immune Checkpoint Inhibitor for Metastatic Lung Cancer in the Small Intestine: A Case Report.
Journal: Cureus
Published: December 17, 2024
A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study): primary analysis.
Journal: Therapeutic advances in medical oncology
Published: August 10, 2022
Prospective analysis of factors precluding the initiation of durvalumab from an interim analysis of a phase II trial of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small cell lung cancer in Japan (SAMURAI study).
Journal: Therapeutic advances in medical oncology
Published: April 07, 2022
Respiratory frequency-tunable dynamic imaging for lung function: New exam method using chest X-ray cine imaging considering various respiratory diseases.
Journal: PloS one
Published: November 30, 2021
A prospective, phase II trial of monotherapy with low-dose afatinib for patients with EGFR, mutation-positive, non-small cell lung cancer: Thoracic oncology research group 1632.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 19, 2021
A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study).
Journal: Therapeutic advances in medical oncology
Published: November 10, 2020
Association of pharmacokinetics and pharmacogenomics with safety and efficacy of gefitinib in patients with EGFR mutation positive advanced non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 21, 2015
High exposure to erlotinib and severe drug-induced interstitial lung disease in patients with non-small-cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: July 03, 2014
Evaluation of the safety and efficacy of combination chemotherapy with vinorelbine and platinum agents for patients with non-small cell lung cancer with interstitial lung disease.
Journal: Anticancer research
Published: December 11, 2012
Phase II study of concurrent chemoradiotherapy with carboplatin and vinorelbine for locally advanced non-small-cell lung cancer.
Journal: Molecular and clinical oncology
Published: October 10, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026